首页 >
法规速递
-
国家药监局关于发布仿制药参比制剂目录（第一百零一批）的通告（2026年第3号）-2026/1/28
2026-01-28查看详情 > -
Page: Variations not requiring assessment (veterinary medicines)-2026/3/5
2026-03-06查看详情 > -
国家药监局关于发布《化妆品用生物技术来源原料技术要求通则》等5项化妆品行业标准的公告（2026年第34号）-2026/4/7
2026-04-08查看详情 > -
Document: Agenda of the CVMP meeting 19-21 May 2026-2026/5/19
2026-05-20查看详情 > -
ANDAs: Pre-Submission Facility Correspondence Related to Prioritized Generic Drug Submissions (Draft)-2022/12/2
2022-12-05查看详情 > -
Draft Guidance: Psychedelic Drugs: Considerations for Clinical Investigations-2023/6/23
2023-06-25查看详情 > -
国家药监局综合司公开征求《药品生产质量管理规范》血液制品附录（修订稿征求意见稿）意见-2023/12/26
2024-01-03查看详情 > -
中药保护品种公告(第22号)(2025年第8号) -2025/1/21
2025-01-23查看详情 > -
Document: Agenda - PDCO agenda of the 25-28 February 2025 meeting-2025/2/26
2025-02-27查看详情 > -
Document: Joint HTAb-regulatory perspectives on understanding evidence challenges, managing uncertainties and exploring potential solutions-2025/4/2
2025-04-03查看详情 >
